Spiral Microfluidic Device for Exosome Isolation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for isolating exosomes from blood are laborious, prone to protein contamination, and have low throughput, with existing microfluidic devices facing challenges in resolving sub-300 nm separation and efficiently processing whole blood due to clogging and low recovery rates.
Innovation Solution
A microfluidic device with a spiral-shaped channel and two inlet ports, one proximal to the inner and one to the outer wall, uses Dean flow separation to isolate exosomes by driving a blood sample and sheath fluid through the channel, with a longer outlet channel for improved separation resolution and high throughput processing.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Manufacturing precision
If multi-step differential and ultracentrifugation is used to isolate EVs, then purity of isolated EVs is improved, but the process becomes laborious and time-consuming
Solution Approach 1:
The patent replaces the complex mechanical ultracentrifugation system with a microfluidic device that uses controlled fluid flow and centrifugal forces generated by the device itself. The microfluidic chip integrates sample introduction, centrifugal separation, and collection functions, eliminating the need for external ultracentrifugation equipment and multiple manual steps while maintaining separation effectiveness.
Solution Approach 2:
The patent combines multiple isolation steps into a single integrated microfluidic device. The device performs cell depletion, platelet removal, and exosome separation in one continuous flow process, merging functions that traditionally required separate centrifugation steps into a unified system that processes samples automatically without manual intervention between steps.
2Reliability
If immunomagnetic bead-based capture is used to isolate exosomes, then isolation effectiveness is improved, but analysis becomes biased depending on binding targets
Solution Approach 1:
The patent extracts exosomes from the complex blood matrix using physical size-based separation rather than immunological binding. By removing exosomes through centrifugal forces and size-dependent migration in the microfluidic channel, the method eliminates dependency on specific surface markers, allowing analysis of exosomes regardless of their protein composition or marker expression.
Solution Approach 2:
The patent changes the isolation parameter from immunological binding affinity to physical size and density characteristics. The microfluidic device exploits the size difference between exosomes and other blood components, using controlled centrifugal forces to separate particles based on their physical properties rather than their molecular targets, thereby providing unbiased isolation.
3Ease of operation
If filtration or precipitation methods are used to isolate EVs, then ease of operation is improved, but purity decreases and EV functionalities may be lost
Solution Approach 1:
The patent replaces chemical precipitation and filtration mechanisms with controlled microfluidic centrifugal separation. The device uses precisely controlled fluid flow and centrifugal forces to separate exosomes based on size and density, avoiding the non-specific binding and potential functional alteration associated with chemical precipitants and filtration membranes.
4Manufacturing precision
If affinity capture using surface markers is used in microfluidic devices, then isolation specificity is improved, but throughput is limited due to low flow rates
Solution Approach 1:
The patent replaces affinity-based capture mechanisms with size-based centrifugal separation. The microfluidic device generates controlled centrifugal forces that cause particles to migrate radially outward based on their size and density, enabling rapid separation without the need for slow binding kinetics. This allows much higher flow rates while maintaining separation specificity based on physical properties rather than molecular recognition.
5Productivity
If size-based exclusion filtration is used to isolate exosomes, then throughput is improved, but device operations are limited by clogging and low EV recovery
Solution Approach 1:
The patent replaces filtration-based size exclusion with centrifugal separation in a microfluidic channel. Instead of forcing blood through porous membranes that clog with cellular components, the device uses controlled centrifugal forces to separate particles in suspension based on their size and density. This eliminates the clogging problem entirely while maintaining high throughput and improving exosome recovery through continuous flow processing.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The method achieves efficient, label-free, high-throughput isolation of exosomes from whole blood with improved resolution and yield, reducing manual labor and costs, and is scalable for clinical applications.
Implementation Method 1
The present methods and microfluidic device involve, for example, the use of a 2-inlet and at least a 2-outlet (e.g., 4-outlet) system spiral microchannel that can demonstrate multiplexed size-based fractionation of EVs (exosomes (50-200 nm) and microvesicles (100 nm-1 μm), platelets (2-3 μm) and blood cells (>8 μm) into the different outlets
Data Source
AI summary
A method herein to isolate exosomes includes providing a microfluidic device having a spiral-shaped channel in fluid communication with two inlet ports and at least two outlet ports. One of the two inlet ports is proximal to an inner wall of the spiral-shaped channel and the other is proximal to an outer wall thereof. At least one of the outlet ports is in fluid communication with a container for storing isolated exosomes. A blood sample and sheath fluid are introduced into the inlet ports proximal to the outer and inner walls, respectively, to form a diluted sample in the spiral-shaped channel and driven through for exosomes recovery in the container. The spiral-shaped channel in fluid communication with a first outlet port includes a first outlet channel connecting the spiral-shaped channel to the first outlet port and is longer than other outlet channels respectively connecting the spiral-shaped channel to the other outlet ports. A method of identifying diabetes mellitus is also disclosed herein.